Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness
- PMID: 10584601
- DOI: 10.1016/s0025-7125(05)70173-5
Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness
Abstract
Evidence demonstrating the burden of prostate cancer upon men in the United States is incontrovertible; less compelling, however, is proof of benefit from early detection efforts. Nevertheless, the absence of definitive evidence does not lessen the interest of men in prostate testing or the obligation of physicians to help interested men make well-informed decisions, which integrate personal circumstance and preference with the best available data. This article provides the counseling physician with the information required to frame the current prostate testing debate and an approach to support informed decision making by men who can benefit from their assistance.
Similar articles
-
The impact of informed consent on patient interest in prostate-specific antigen screening.Arch Intern Med. 1996 Jun 24;156(12):1333-6. Arch Intern Med. 1996. PMID: 8651843 Clinical Trial.
-
National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.Cancer. 2014 May 15;120(10):1491-8. doi: 10.1002/cncr.28600. Epub 2014 Feb 12. Cancer. 2014. PMID: 24523016
-
Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.J Med Screen. 2003;10(1):27-39. doi: 10.1258/096914103321610789. J Med Screen. 2003. PMID: 12790313 Clinical Trial.
-
Promoting informed decision making about prostate cancer screening.Compr Ther. 2001 Fall;27(3):195-201. doi: 10.1007/s12019-001-0014-4. Compr Ther. 2001. PMID: 11569319 Review.
-
American Cancer Society guideline for the early detection of prostate cancer: update 2010.CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3. CA Cancer J Clin. 2010. PMID: 20200110 Review.
Cited by
-
Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites.Am J Public Health. 2004 Aug;94(8):1336-8. doi: 10.2105/ajph.94.8.1336. Am J Public Health. 2004. PMID: 15284039 Free PMC article.
-
Prostate cancer screening among chinese american men: a structural model.Am J Health Behav. 2012 Jul;36(4):495-504. doi: 10.5993/AJHB.36.4.6. Am J Health Behav. 2012. PMID: 22488399 Free PMC article.
-
Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial.Am J Prev Med. 2007 Aug;33(2):83-90. doi: 10.1016/j.amepre.2007.03.018. Am J Prev Med. 2007. PMID: 17673094 Free PMC article. Clinical Trial.
-
Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?Am J Public Health. 2003 May;93(5):779-85. doi: 10.2105/ajph.93.5.779. Am J Public Health. 2003. PMID: 12721144 Free PMC article.
-
Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.J Gen Intern Med. 2003 May;18(5):350-6. doi: 10.1046/j.1525-1497.2003.20626.x. J Gen Intern Med. 2003. PMID: 12795733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical